Marksans Pharma Reports Strong December 2025 Quarter: Net Sales Up 8.93% YoY to Rs 339.73 Crore

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Marksans Pharma Sees Strong Q3 Growth: Net Sales Up 8.93%, Profit Jumps 9.82%

Marksans Pharma Sees Strong Q3 Growth: Net Sales Up 8.93%, Profit Jumps 9.82%

M

Moneycontrol•09-02-2026, 11:29

Marksans Pharma Sees Strong Q3 Growth: Net Sales Up 8.93%, Profit Jumps 9.82%

•Marksans Pharma reported standalone net sales of Rs 339.73 crore in December 2025, an 8.93% increase year-on-year.
•Quarterly net profit rose by 9.82% to Rs 60.91 crore in December 2025, compared to Rs 55.46 crore in December 2024.
•EBITDA for December 2025 stood at Rs 91.30 crore, marking a 10.73% increase from the previous year.
•Earnings Per Share (EPS) improved to Rs 1.34 in December 2025 from Rs 1.22 in December 2024.
•Despite strong quarterly results, Marksans Pharma shares have seen negative returns of -17.79% over 6 months and -34.13% over 12 months.

Read Full Article on Moneycontrol in English

✦

More like this

✦

More like this

Aurobindo Pharma Q3 Net Profit Jumps 23.31% Despite Sales Dip

Aurobindo Pharma Q3 Net Profit Jumps 23.31% Despite Sales Dip

U. Y. Fincorp's Net Sales Soar 175.95% in Dec 2025 Quarter

U. Y. Fincorp's Net Sales Soar 175.95% in Dec 2025 Quarter

Bharti Hexacom's Net Sales Up 4.85%, Net Profit Soars 81.56% in Dec 2025 Quarter

Bharti Hexacom's Net Sales Up 4.85%, Net Profit Soars 81.56% in Dec 2025 Quarter

Stock market today

GlaxoSmithKline Pharma Shares Dip 2.02% Intraday Amid Strong Financials

PVR INOX Q3 2025: Net Sales Up 11.14%, Profit Soars 175.36% Y-o-Y

PVR INOX Q3 2025: Net Sales Up 11.14%, Profit Soars 175.36% Y-o-Y

VB Desai Fin Reports Mixed Q3 2025 Results: Net Sales Down, Profit Up

VB Desai Fin Reports Mixed Q3 2025 Results: Net Sales Down, Profit Up